Last reviewed · How we verify
NCT05450627
Registry of Pancreatic Exocrine Insufficiency.
trial testing Pancreatic Enzyme in Exocrine Pancreatic Insufficiency in 1,000 participants. Status unknown.
30 June 2023
Quick facts
| Lead sponsor | Hospital Clinico Universitario de Santiago |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 1 June 2021 |
| Primary completion | 30 June 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Pancreatic Enzyme — full drug profile →
Conditions studied
- Exocrine Pancreatic Insufficiency — all drugs for Exocrine Pancreatic Insufficiency →
Sponsor
Hospital Clinico Universitario de Santiago
Who can join
18 and older, any sex, with Exocrine Pancreatic Insufficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective, cross-sectional, observational study has been designed with the aim of the study is to evaluate the diagnosis and management of patients with pancreatic exocrine insufficiency secondary to different pancreatic diseases and conditions in clinical practice. A registry has been develop to include patients older than 18 years diagnosed with pancreatic exocrine insufficiency, sho are willing to participate in the study and sign the informed consent. Registry includes demographics, toxic habits,pharmacological therapies, underlying disease that causes pancreatic exocrine insufficiency.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05450627
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pancreatic Enzyme
Trials testing the same drug.
- NCT04542473 — Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children · Phase 2, PHASE3 · unknown
- NCT03097029 — Use of Pancreatic Enzymes in Short Bowel Syndrome · Phase 2 · completed
Other recruiting trials for Exocrine Pancreatic Insufficiency
Currently open trials in the same condition.
- NCT05710315 — Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure · NA · recruiting
- NCT06477159 — Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency · Phase 4 · recruiting
- NCT05112328 — The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding · NA · recruiting
Other Hospital Clinico Universitario de Santiago trials
Trials by the same sponsor.
- NCT07495436 — Video Versus Direct Laryngoscopy for Tracheal Intubation in Pediatric Surgery · NA · not yet recruiting
- NCT07347158 — Effectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiet · NA · enrolling by invitation
- NCT06401486 — DOuble-Lumen Intubation With VIdeolaryngoscopy · NA · completed
- NCT06725966 — Personalized Treatment of Refractory BPPV · NA · recruiting
- NCT06322719 — Hyperangulated vs Macintosh Blades for Intubation With Videolaryngoscopy in ICU · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05450627 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Clinico Universitario de Santiago
- Last refreshed: 11 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05450627.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing